Lucid Diagnostics Inc. (LUCD)
Largest Insider Buys in Sector
LUCD Stock Price History Chart
LUCD Stock Performance
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, …
Insider Activity of Lucid Diagnostics Inc.
Over the last 12 months, insiders at Lucid Diagnostics Inc. have bought $0 and sold $0 worth of Lucid Diagnostics Inc. stock.
On average, over the past 5 years, insiders at Lucid Diagnostics Inc. have bought $8M and sold $53,408 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 571,428 shares for transaction amount of $8M was made by PAVmed Inc. (10 percent owner) on 2021‑10‑18.
List of Insider Buy and Sell Transactions, Lucid Diagnostics Inc.
| 2023-09-26 | Sale | director | 29,747 0.0667% | $1.45 | $43,173 | -22.66% | ||
| 2023-09-25 | Sale | director | 200 0.0005% | $1.43 | $286 | -19.62% | ||
| 2023-09-21 | Sale | director | 100 0.0002% | $1.44 | $144 | -19.44% | ||
| 2023-09-20 | Sale | director | 3,817 0.0087% | $1.45 | $5,531 | -19.31% | ||
| 2022-09-20 | Sale | director | 33,864 0.0916% | $1.70 | $57,683 | -13.29% | ||
| 2021-10-18 | 10 percent owner | 571,428 4.5992% | $14.00 | $8M | -67.86% |
Insider Historical Profitability
| PAVmed Inc. | 10 percent owner | 27927190 47.061% | $0.76 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Luminus Management Llc | $581,230.00 | 1.38 | 717,657 | -7.19% | -$45,021.50 | 0.09 | |
| The Vanguard Group | $454,285.00 | 1.08 | 560,915 | +68.75% | +$185,081.56 | <0.0001 | |
| Geode Capital Management | $126,166.00 | 0.3 | 155,757 | +18.11% | +$19,348.09 | <0.0001 | |
| Nantahala Capital Management Llc | $132,281.00 | 0.29 | 149,698 | 0% | +$0 | 0.01 | |
| Jane Street Capital | $98,818.00 | 0.23 | 122,013 | +888.36% | +$88,819.82 | <0.0001 |